Author:
Dudley Matthew Z.,Salmon Daniel A.,Halsey Neal A.,Orenstein Walter A.,Limaye Rupali J.,O’Leary Sean T.,Omer Saad B.
Publisher
Springer International Publishing
Reference17 articles.
1. Mutsch, M., et al., Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med, 2004. 350(9): p. 896–903.
2. Institute of Medicine, in Adverse Effects of Vaccines: Evidence and Causality, K. Stratton, et al., Editors. 2012, National Academies Press (US): Washington (DC).
3. Greene, S.K., et al., Near real-time surveillance for influenza vaccine safety: Proof-of-concept in the vaccine safety datalink project. American Journal of Epidemiology, 2010. 171(2): p. 177–88.
4. Stowe, J., et al., Bell's palsy and parenteral inactivated influenza vaccine. Hum Vaccin, 2006. 2(3): p. 110–2.
5. Yih, W.K., et al., An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink. Vaccine, 2009. 27(32): p. 4257–62.